LP
| |
Lion Point Capital, LP13F | |
| Lion Point Capital, LP | |
| Last update 2025-05-15 | 21 Stocks (2 new) |
| Value $16.00 Mil | Turnover 7 % |
Lion Point Capital, LP Top Holdings of 2025-03-31
View Full List
| Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INSM | Insmed Inc | 30,500 | 2,326.8 | -16.89% | 14.840 | -2.24% | 0.020 | +43.39% | +50.88% | 19,787.2 | Biotechnology | |
ARDX | Ardelyx Inc | 335,400 | 1,646.8 | 0% | 10.510 | 0% | 0.140 | -4.88% | -9.66% | 1,095.8 | Biotechnology | |
MLYS | Mineralys Therapeutics Inc | 79,000 | 1,254.5 | 0% | 8.000 | 0% | 0.120 | +7.15% | +16.21% | 932.3 | Biotechnology | |
FENC | Fennec Pharmaceuticals Inc | 195,700 | 1,191.8 | 0% | 7.600 | 0% | 0.710 | +74.21% | +40.03% | 244.4 | Biotechnology | |
KNSA |
Kiniksa Pharmaceuticals International PLC
Kiniksa Pharmaceuticals International PLC
| 45,900 | 1,019.4 | 0% | 6.500 | 0% | 0.060 | +45.25% | +48.41% | 2,142.1 | Drug Manufacturers | |
BBIO | BridgeBio Pharma Inc | 26,000 | 898.8 | -35.48% | 5.730 | -2.05% | 0.010 | +38.00% | +70.34% | 8,875.0 | Biotechnology | |
BNTC | Benitec Biopharma Inc | 62,000 | 806.6 | 0% | 5.150 | 0% | 0.240 | -13.67% | -6.02% | 311.6 | Biotechnology | |
GERN | Geron Corp | 500,000 | 795.0 | 0% | 5.070 | 0% | 0.080 | +4.45% | -62.53% | 844.9 | Biotechnology | |
AVDL | Avadel Pharmaceuticals PLC | 98,700 | 772.8 | +54.22% | 4.930 | +1.73% | 0.100 | +35.37% | +3.43% | 1,053.3 | Drug Manufacturers | |
ARQT | Arcutis Biotherapeutics Inc | 46,300 | 724.1 | 0% | 4.620 | 0% | 0.040 | +19.95% | +12.02% | 1,860.1 | Biotechnology |
Lion Point Capital, LP's Historical Top Holdings Breakdowns
Lion Point Capital, LP's Top Stock Picks
View Full List
| Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
|---|---|---|---|---|---|---|---|---|---|---|---|
MIST | Milestone Pharmaceuticals Inc | 2025-03-31 | Reduce Reduce | -5.90% | 0.8 ($1.99) 2.41 | $1.64 | -17.59% | Reduce -46.5% | 548,806 | -477,000 | |
JSPR | Jasper Therapeutics Inc | 2025-03-31 | Add Add | +3.14% | 4.3 ($6.65) 21.09 | $3.37 | -49.32% | Add 357.81% | 146,500 | 114,500 | |
INSM | Insmed Inc | 2025-03-31 | Reduce Reduce | -2.24% | 65.25 ($76.49) 83.83 | $104.43 | 36.53% | Reduce -16.89% | 30,500 | -6,200 | |
BBIO | BridgeBio Pharma Inc | 2025-03-31 | Reduce Reduce | -2.05% | 28.12 ($33.72) 37.59 | $46.74 | 38.61% | Reduce -35.48% | 26,000 | -14,300 | |
AVDL | Avadel Pharmaceuticals PLC | 2025-03-31 | Add Add | +1.73% | 7.49 ($8.37) 11.06 | $10.87 | 29.87% | Add 54.22% | 98,700 | 34,700 | |
MRSN | Mersana Therapeutics Inc | 2025-03-31 | New Buy New Buy | +1.41% | 0.34 ($0.62) 1.4 | $0.36 | -41.40% | New holding | 644,000 | 644,000 | |
HUMA | Humacyte Inc | 2025-03-31 | New Buy New Buy | +0.91% | 1.71 ($3.75) 5.18 | $2.47 | -34.13% | New holding | 83,500 | 83,500 | |
MRNS | Marinus Pharmaceuticals Inc | 2024-12-31 | Sold Out Sold Out | -2.72% | 0.23 ($0.68) 1.85 | $0.55 | -19.12% | Sold Out | 0 | -693,778 | |
INSM | Insmed Inc | 2024-12-31 | Reduce Reduce | -2.52% | 66.29 ($72.01) 76.65 | $104.43 | 45.02% | Reduce -29.69% | 36,700 | -15,500 | |
MIST | Milestone Pharmaceuticals Inc | 2024-12-31 | Reduce Reduce | -2.13% | 1.43 ($1.72) 2.36 | $1.64 | -4.65% | Reduce -37.99% | 1,025,806 | -628,348 |
Lion Point Capital, LP Total Holding History ($B)
Lion Point Capital, LP's Asset Allocation
Lion Point Capital, LP Past Portfolios
| Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
|---|---|---|---|---|
Top Ranked Articles
- 1
Lion Point Capital, LP's Hypothetical Growth since 2025-03-31
Lion Point Capital, LP's Yearly Returns
| Year | Portfolio % | % | Excess Gain % |
|---|
Lion Point Capital, LP's Holdings Heat Map
Size field:
Lion Point Capital, LP's Holdings Bubble Chart
Lion Point Capital, LP News
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers